Five years after Taiwan first urged medical device manufacturers to include unique identification (UDI) codes on the labels of their products, regulators are seeking public consultation on making the voluntary labeling protocols mandatory. The draft requirements would mandate UDI labels include a... Read More
Sales of diagnostic mammography equipment in the Asia-Pacific region is expected to rise significantly over the next eight years, according to two recently published studies. The reports by Globalcan and GlobalData vary in their specific findings. But both project compound annual growth... Read More
Radio Frequency Identification (RFID), a fast-developing technology that uses radio waves to collect and transfer data, is increasingly being adopted in healthcare markets across the Asia Pacific region and around the globe. A study by Precedence Research found sales of the technology,... Read More
Medical devices which employ artificial intelligence and machine learning will be subject to new inspection and registration guidelines in Taiwan, according to directives published in October by Taiwan’s Food and Drug Administration. The new structures are designed to ensure that medical device... Read More
Fees to register and obtain licenses for the sale of medical devices in Taiwan will increase next year, the country’s Food and Drug Administration (TFDA) announced in August. Under the new fee structure, registration fees for Class I devices will increase from... Read More
This article was originally published on MedTech Intelligence China In China, where the vast medical device market was valued at more than $40 billion in 2019, authorities have moved to secure the safety and efficacy of medical devices while at the same... Read More
Seeking to align Taiwan’s pharmaceutical clinical practice methods with international standards, the nation’s top health safety agency is strengthening its protocols for review and approval of new drugs. Starting July 1, 2021, Taiwan’s Food and Drug Administration (FDA) will require that... Read More
Aging populations and increased incidences of chronic diseases across the Asia-Pacific region are spurring rapid growth in demand for in-vitro diagnostic (IVD) testing. That presents major marketing opportunities for the diagnostics industry in China, India, Southeast Asia, Japan, South Korea, and Indonesia. ... Read More
The COVID-19 pandemic is hampering the initiation and progress of clinical trials in Asia and around the world. Few patients are entering studies, and trials of new treatments are on hold. In Korea, the number of new patients enrolling in clinical... Read More